Researchers from the Germans Trias i Pujol Research Institute (IGTP), the Biomedical Research Networking Center on Cardiovascular Diseases (CIBERCV), the University of Barcelona and the the Universitat Politècnica de Catalunya have created a new field probe to detect the presence of metallic stents as well as their potential structural failures through microwave spectrometry (MWS) in a non-invasive and non-ionizing way. Results have been published in the journal Scientific Reports.
New IGTP spin-off to develop gene therapy for Friedreich’s ataxia, a rare neurodegenerative disease
Biointaxis, the new spin-off company of the IGTP, was recently constituted. The company stems from research led by Dr Antoni Matilla-Dueñas together with Dr Ivelisse Sánchez of the Neurogenetics Group of the IGTP and has been created to increase translational research leading to treatments and new genomic technologies for rare neurological diseases with genetic causes. The first project the company is undertaking is the development of a gene therapy for Friedreich's Ataxia.
Mon 29 October 15.00 IJC SEMINAR DNA replication defects: a cause and vulnerability in cancer treatment Travis Stracker, IRB
Auditorium IJC Building More information
Tues 30 October 15.00-18.30 PROJECTS OFFICE INFORMATION SESSION Salud, Cambio Demográfico y bienestar H2020 Reto Social Juan Riese, PhD, ISCIII
Venue: Sala Polivalent, IGTP Mar More information
Weds 31 October 15.00 COFFEE TALK Oscar Blanch-Lobarte, Virievac Group, IrsiCaixa Adrián Villalba, Immunology of Diabetes Group, IGTP
Sala Polivalent, IGTP Mar
Monday 5 November 15.00 CAN RUTI BIOMEDICAL RESEARCH SEMINAR
Targeting epigenetic factors for tailored intervention against malaria parasites Artur Scherf, CNRS Research Director (DRCE), Professor at the Institut Pasteur, Paris, France
Host: Hernando A. del Portillo, IGTP & IsGlobal More information
Weds 7 November 10.00-14.00 SESSIÓ DE DONACIÓ DE SANG
Sala Polivalent, IGTP Mar
Weds 7 November 15.00 COFFEE TALK Oscar Blanch-Lombarte, Viral Immune Evasion and Vaccines (Virievac) Group, IrisiCaixa Richard Norris, Regulatory Endocrine Genomics, IJC
Sala Polivalent, IGTP Mar
This Newsletter is for information only Please check all information on the corresponding sites
The IGTP is not responsible for the content of webpages that the user can access through links in this newsletter. The IGTP cannot examine or control the content of other sites on the web, nor can it guarantee the availability, truth, accuracy, validity or legality of sites that are not its property, but that can be accessed via links.
